Protein paucimannosylation is an enriched N-gycosylation signature of human cancers (2019)
- Authors:
- Chatterjee, Sayantani
- Lee, Ling Y.
- Kawahara, Rebeca
- Abrahams, Jodie L.
- Adamczyk, Barbara
- Anugraham, Merrina
- Ashwood, Christopher
- Sumer‐Bayraktar, Zeynep
- Briggs, Matthew T.
- Chik, Jenny H. L.
- Everest‐Dass, Arun
- Förster, Sarah
- Hinneburg, Hannes
- Leite, Katia Ramos Moreira
- Loke, Ian
- Möginger, Uwe
- Moh, Edward S. X.
- Nakano, Miyako
- Recuero, Saulo
- Sethi, Manveen K.
- Srougi, Miguel
- Stavenhagen, Kathrin
- Venkatakrishnan, Vignesh
- Wongtrakul‐Kish, Katherine
- Diestel, Simone
- Hoffmann, Peter
- Karlsson, Niclas G.
- Kolarich, Daniel
- Molloy, Mark P.
- Muders, Michael H.
- Oehler, Martin K.
- Packer, Nicolle H.
- Palmisano, Giuseppe
- Thaysen‐Andersen, Morten
- Chatterjee, Sayantani
- USP affiliated authors: LEITE, KATIA RAMOS MOREIRA - FM ; RECUERO, SAULO DA CUNHA - FM ; SROUGI, MIGUEL - FM ; PALMISANO, GIUSEPPE - ICB
- Unidades: FM; ICB
- DOI: 10.1002/pmic.201900010
- Subjects: PARASITOLOGIA; NEOPLASIAS; LEUCEMIA; NEOPLASIAS HEPÁTICAS; METÁSTASE NEOPLÁSICA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Proteomics
- ISSN: 1615-9861
- Volume/Número/Paginação/Ano: art. 1900010, p. 1-13, 2019
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
CHATTERJEE, Sayantani et al. Protein paucimannosylation is an enriched N-gycosylation signature of human cancers. Proteomics, p. 1-13, 2019Tradução . . Disponível em: https://doi.org/10.1002/pmic.201900010. Acesso em: 17 fev. 2026. -
APA
Chatterjee, S., Lee, L. Y., Kawahara, R., Abrahams, J. L., Adamczyk, B., Anugraham, M., et al. (2019). Protein paucimannosylation is an enriched N-gycosylation signature of human cancers. Proteomics, 1-13. doi:10.1002/pmic.201900010 -
NLM
Chatterjee S, Lee LY, Kawahara R, Abrahams JL, Adamczyk B, Anugraham M, Ashwood C, Sumer‐Bayraktar Z, Briggs MT, Chik JHL, Everest‐Dass A, Förster S, Hinneburg H, Leite KRM, Loke I, Möginger U, Moh ESX, Nakano M, Recuero S, Sethi MK, Srougi M, Stavenhagen K, Venkatakrishnan V, Wongtrakul‐Kish K, Diestel S, Hoffmann P, Karlsson NG, Kolarich D, Molloy MP, Muders MH, Oehler MK, Packer NH, Palmisano G, Thaysen‐Andersen M. Protein paucimannosylation is an enriched N-gycosylation signature of human cancers [Internet]. Proteomics. 2019 ; 1-13.[citado 2026 fev. 17 ] Available from: https://doi.org/10.1002/pmic.201900010 -
Vancouver
Chatterjee S, Lee LY, Kawahara R, Abrahams JL, Adamczyk B, Anugraham M, Ashwood C, Sumer‐Bayraktar Z, Briggs MT, Chik JHL, Everest‐Dass A, Förster S, Hinneburg H, Leite KRM, Loke I, Möginger U, Moh ESX, Nakano M, Recuero S, Sethi MK, Srougi M, Stavenhagen K, Venkatakrishnan V, Wongtrakul‐Kish K, Diestel S, Hoffmann P, Karlsson NG, Kolarich D, Molloy MP, Muders MH, Oehler MK, Packer NH, Palmisano G, Thaysen‐Andersen M. Protein paucimannosylation is an enriched N-gycosylation signature of human cancers [Internet]. Proteomics. 2019 ; 1-13.[citado 2026 fev. 17 ] Available from: https://doi.org/10.1002/pmic.201900010 - Tissue proteome signatures associated with five grades of prostate cancer and benign prostatic hyperplasia
- The complexity and dynamics of the tissue glycoproteome associated with prostate cancer progression
- Distinct urinary glycoprotein signatures in prostate cancer patients
- Treating metastatic prostate cancer with microRNA-145
- PD-L1 expression in renal cell carcinoma clear cell type is related to unfavorable prognosis
- Prognostic value of TERF1 expression in prostate cancer
- Controlling RECK miR21 promotes tumor cell invasion and is related to biochemical recurrence in prostate cancer
- Upregulation of shelterin and CST genes and longer telomeres are associated with unfavorable prognostic characteristics in prostate cancer
- Histologic abnormalities in non-neoplastic renal parenchyma and the risk of chronic kidney disease following radical nephrectomy
- Shorter leukocyte telomere length is associated with severity of COVID-19 infection.
Informações sobre o DOI: 10.1002/pmic.201900010 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
